We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+10.47%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$100B
AUM Growth
-$306M
(-0.3%)
Cap. Flow
-$14.1B
Cap. Flow
% of AUM
-14.05%
Top 10 Holdings %
Top 10 Hldgs %
29.11%
Holding
2,684
New
51
Increased
454
Reduced
1,847
Closed
245
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$493M |
| 2 |
Home Depot
HD
|
+$300M |
| 3 |
Cadence Design Systems
CDNS
|
+$214M |
| 4 |
Caterpillar
CAT
|
+$204M |
| 5 |
Motorola Solutions
MSI
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$643M |
| 2 |
Boston Scientific
BSX
|
+$452M |
| 3 |
Amazon
AMZN
|
+$417M |
| 4 |
Meta Platforms (Facebook)
META
|
+$328M |
| 5 |
Eli Lilly
LLY
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.43% |
| 2 | Financials | 9.29% |
| 3 | Consumer Discretionary | 8.36% |
| 4 | Industrials | 8.03% |
| 5 | Communication Services | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Humacyte
HUMA
$151M
| $37.9K | ﹤0.01% |
21,796
-12,445
| -36% | -$24.4K |
|
2327
Health Catalyst
HCAT
$133M
| $36.8K | ﹤0.01% |
12,901
-9,227
| -42% | -$31.6K |
|
2328
Perspective Therapeutics
CATX
$356M
| $36.6K | ﹤0.01% |
10,675
-5,871
| -35% | -$21.4K |
|
2329
Codexis
CDXS
$176M
| $36.2K | ﹤0.01% |
14,843
-8,281
| -36% | -$22.6K |
|
2330
Accuray
ARAY
$32.9M
| $35.8K | ﹤0.01% |
21,433
-9,119
| -30% | -$13.5K |
|
2331
W&T Offshore
WTI
$545M
| $35.3K | ﹤0.01% |
19,407
-10,778
| -36% | -$19.1K |
|
2332
MaxCyte
MXCT
$149M
| $35K | ﹤0.01% |
22,158
-9,226
| -29% | -$16K |
|
2333
Heron Therapeutics
HRTX
$63.3M
| $34.8K | ﹤0.01% |
27,653
-15,338
| -36% | -$24.3K |
|
|
BHR
2334
Braemar Hotels & Resorts
BHR
$139M
| $34.7K | ﹤0.01% |
12,697
-6,916
| -35% | -$17.5K |
|
|
OLPX
2335
DELISTED
Olaplex Holdings
OLPX
| $34.5K | ﹤0.01% |
26,357
-14,332
| -35% | -$20.5K |
|
2336
Entravision Communication
EVC
$822M
| $33.3K | ﹤0.01% |
14,304
-7,723
| -35% | -$18.8K |
|
2337
Allogene Therapeutics
ALLO
$683M
| $33.3K | ﹤0.01% |
26,852
-15,671
| -37% | -$18.7K |
|
2338
Aclaris Therapeutics
ACRS
$864M
| $32.8K | ﹤0.01% |
17,248
-9,631
| -36% | -$16.8K |
|
2339
OmniAb
OABI
$497M
| $31.2K | ﹤0.01% |
19,496
-11,076
| -36% | -$20.2K |
|
2340
E.W. Scripps
SSP
$313M
| $30.2K | ﹤0.01% |
12,284
-5,287
| -30% | -$16.3K |
|
2341
Advantage Solutions
ADV
$427M
| $30K | ﹤0.01% |
784
-444
| -36% | -$18.5K |
|
2342
Hain Celestial
HAIN
$54.3M
| $29.8K | ﹤0.01% |
18,838
-8,313
| -31% | -$14.2K |
|
|
TRUE
2343
DELISTED
TrueCar
TRUE
| $29.8K | ﹤0.01% |
16,169
-8,913
| -36% | -$17.9K |
|
2344
Eledon Pharmaceuticals
ELDN
$286M
| $29.6K | ﹤0.01% |
11,420
-6,693
| -37% | -$19.6K |
|
2345
Fate Therapeutics
FATE
$295M
| $28.4K | ﹤0.01% |
22,502
-9,637
| -30% | -$10.4K |
|
2346
SELLAS Life Sciences
SLS
$2.49B
| $28.1K | ﹤0.01% |
17,444
-10,059
| -37% | -$17.9K |
|
2347
Coherus Oncology
CHRS
$176M
| $27.8K | ﹤0.01% |
+16,971
| New | +$18.9K |
|
2348
PLAYSTUDIOS Inc
MYPS
$66M
| $27.7K | ﹤0.01% |
28,796
-4,077
| -12% | -$4.39K |
|
2349
Montauk Renewables
MNTK
$268M
| $27.5K | ﹤0.01% |
13,694
-8,054
| -37% | -$17.3K |
|
2350
Beyond Meat
BYND
$216M
| $27.2K | ﹤0.01% |
14,412
-9,411
| -40% | -$27.7K |
|
Similar funds
VAM
VOYA Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, VOYA Investment Management held 2,684 positions worth $100B, down 0.3% from $100B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VOYA Investment Management withdrew a net $14.1B in Q3 2025, closing 245 positions and reducing 1,847 holdings. Its most notable exit was Trip.com Group, an estimated $144M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, VOYA Investment Management opened a new position in CoreWeave worth $111M.
- VOYA Investment Management's largest Q3 2025 buy was CoreWeave: 807,904 shares worth $111M.
- VOYA Investment Management added most to Alphabet (Google) Class A in Q3 2025, an estimated $493M increase.
- VOYA Investment Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $643M.
- VOYA Investment Management fully exited Trip.com Group in Q3 2025, selling an estimated $144M.
- VOYA Investment Management's ten largest holdings make up 29% of its $100B portfolio in Q3 2025.
- VOYA Investment Management opened 51 new positions and closed 245 in Q3 2025.
- VOYA Investment Management's portfolio value fell 0.3% quarter-over-quarter to $100B.
Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.